1
Anxiety treatment is a clinical question with multiple right answers depending on the disorder and client specifics. Generalized anxiety disorder (GAD) responds differently than panic disorder than social anxiety and health anxiety. The treatment changes accordingly.
Residential anxiety treatment is appropriate when outpatient hasn’t been enough — severe symptoms, co-occurring substance use, treatment-resistant cases, or clients moving off long-term benzodiazepines who need a controlled medication transition. Our depression treatment shares the same psychiatry team for clients with overlapping mood-and-anxiety presentations.
SSRIs first-line: sertraline, escitalopram, fluoxetine. SNRIs second-line: venlafaxine, duloxetine. Buspirone (Buspar) for GAD without dependence risk. Hydroxyzine (Vistaril) for acute use. Propranolol for performance anxiety. Gabapentin for off-label anxiety augmentation. We don’t reach for benzodiazepines as first-line — and our benzo residential program explains why in detail.
Exposure therapy is the evidence-based behavioral intervention for anxiety. Graded exposure for panic. Cognitive-behavioral therapy for cognitive distortions. Somatic regulation — vagal tone exercises, breathwork, grounding — for body-level anxiety. We integrate all three. The non-benzo anxiety medication framework runs in parallel with exposure work, not instead of it.
For clients who arrive on Klonopin, Xanax, or other long-term benzodiazepines and want to come off, we coordinate slow taper with non-benzo replacement strategies. The taper continues from benzo detox if applicable. We’ve found that anxiety treatment goes well when clients accept it’s a process — not a switch.
Resort-Style Pool
Spa, Sauna & Wellness Suite
Chef-Prepared Meals DailyYes — and benzodiazepines aren’t first-line for chronic anxiety. The non-benzo anxiety medication menu covers most clinical situations. SSRIs (sertraline, escitalopram, fluoxetine) and SNRIs (venlafaxine, duloxetine) are first-line for GAD, panic, and social anxiety. Buspirone (Buspar) treats GAD without dependence risk. Hydroxyzine (Vistaril) handles acute use without sedation tolerance. Propranolol manages performance-anxiety physiology. Gabapentin can augment when SSRIs alone aren’t enough. Why non-benzo? Benzodiazepines develop tolerance — they treat acute symptoms but make underlying anxiety harder to resolve. For clients moving off long-term benzodiazepines, see our benzo residential program for the structured taper.
Interoceptive exposure — graded exposure to bodily sensations that resemble panic — is the evidence-based behavioral treatment for panic disorder. SSRI medication (sertraline, escitalopram) when symptoms warrant. Cardiac workup first to rule out organic causes; some apparent panic is actually arrhythmia or thyroid dysfunction. Why interoceptive specifically? Panic disorder is a learned-fear-of-bodily-sensations problem. The work is reteaching the nervous system that increased heart rate or shortness of breath isn’t catastrophic. Residential matters when panic is interfering with daily function or has driven substance use. For clients who developed benzodiazepine dependence around panic, our benzo residential program handles the dual track.
Social anxiety treatment in residential is graded exposure plus cognitive restructuring. SSRI medication for severe cases. Propranolol for the performance-anxiety subtype where physical symptoms are the primary problem. Group therapy is exposure itself — practiced with clinical structure and built-in feedback. Why residential matters: daily structured exposure opportunities competitors can’t replicate. Outpatient social-anxiety work depends on clients exposing themselves between sessions, which the disorder itself often prevents. Residential builds exposure into the daily schedule. See our recovery programs hub for cross-presentations with substance use.
Most major commercial insurers cover residential anxiety treatment under MHPAEA mental-health parity laws. Coverage commonly extends to Anthem Blue Cross of California, Aetna, Cigna, Carelon Behavioral Health, UnitedHealthcare, Empire Plan / NYSHIP, and Magellan Health. Same-day verification is standard at GEVS. Long-term benzodiazepine-transition cases often have strong coverage when the medical necessity is documented — we handle the documentation. To start the verification process, see our verify your insurance page or call (844) 501-5005.